New publication finds highly accurate molecular diagnoses of facioscapulohumeral muscular dystrophy (FSHD), a hereditary muscle disease
Relive the biggest stories of the month and find out what’s been making waves in the SelectScience life sciences community since the turn of the year
Dr. Jim Aguanno explores the role of natriuretic peptides – NT-proBNP and BNP – in the diagnosis of heart failure
Just leave a quick lab product review today for your chance to scoop the $100 Grand Prize this week
Stream Bio launches new range of Streptavidin-linked CPNs
In this SelectScience special feature dedicated to protein biology, discover methods to improve your experiments
New results suggest the MammaTyper test could predict the likelihood of complete pathologic remission
Dr. Masato Nakagawa to discuss induced pluripotent stem cells for regenerative research
Five color, high-performance immunohistochemistry multiplexing solution to advance biomarker studies
Team heading to San Diego, USA, to interview leading neuroscientists and report on the newest technologies
AMSBIO announces the launch of a new range of circulating tumor DNA (ctDNA) reference standards for cancer disease management research
Research shows adding Abbott's High Sensitive Troponin-I diagnostic test to doctors' existing standard of care can help more accurately determine a person's chances of a heart attack or other cardiac event potentially months to years in advance
Citrullinated histone 3 found to be associated with increased risk of thrombosis and inflammation
Learn about the different approaches that scientists are taking towards precision medicine
We bring you insights, tips and knowledge from 11 experts as they tackle biomarker research using diverse methods
Discover the nano-LC technology enabling lipidomic research
SelectScience will be attending the AACC Annual Meeting in Chicago, USA, to interview leading scientists and report on the latest technologies
The findings could help clinicians decide the best course and delivery of treatment for cancer patients
Breakthrough research of faecal metabolites could lead to personalized obesity treatments within a decade
The immunoassay is the market’s first validated high-performance multiplex screening panel
